mounjaro patent expiration date tirzepatide patent expiry When will the patents on expire, and when will generic MOUNJARO be available? 🚨 Generic Versions of Mounjaro

Across multiple phase III trials, tirzepatide has consistently produced greater reductions in glycated hemoglobin and body weight compared with established GLP 1 receptor agonists and other standard therapies

doi: 10.14309/ajg.0000000000001306 39 PaineP

doi:10.1152/ajpheart.2001.280.1.H108 Vitko D, Chou WF, Nouri Golmaei S, et al

Abstract GLP-1 receptor agonists used for the treatment of diabetes, have shown some neuroprotective effects in cellular and animal models of Alzheimers disease (AD) and Parkinsons disease (PD)

Stomach problems are common among Ozempic users

However, Wegovy, the 2.4 mg dose, is approved for chronic weight management whether or not the person has diabetes